NCT02890485

Brief Summary

This study is testing the effectiveness of "dry needling" for pain management and on muscle strength and leg function for those with knee pain. Dry needling consists of small, monofilament needles that are administered directly into the tissue and manipulated to make the muscle relax for pain relief. This technique is used to treat dysfunctions in skeletal muscle and connective tissue to help diminish pain, reduce impairments of body structure and restore function.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
56mo left

Started Aug 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Aug 2016Dec 2030

Study Start

First participant enrolled

August 1, 2016

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 29, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 7, 2016

Completed
12.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

12.3 years

First QC Date

August 29, 2016

Last Update Submit

February 23, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline Anterior Knee Pain Scale (AKPS) score to 3 weeks

    The AKPS is commonly used to evaluate function in patients with PFPS. It is a 13-item questionnaire with a maximum score of 100. Higher scores are indicative of better function. The minimal detectable change (MDC) and the minimal clinically important difference (MCID) of the AKPS has been reported to be 10 and 13 points respectively and has high test-retest reliability (ICC: 0.81 to 0.95). The standard error of measurement is 3 and has been shown to be valid (0.92).

    Baseline and Post testing (week 3)

  • Change from Baseline Numeric Pain Rating Scale (NPRS) score to 3 weeks

    Pain will be measured using the numeric pain rating scale (NPRS). Patients will be asked to rate their pain on 11-point (0-10) scale with 0 being no pain and 10 being extreme pain. The NPRS is a common measure of pain in patients with PFPS and has been shown to be reliable and responsive (minimal clinically important difference = 2 points).

    Baseline and Post testing (week 3)

Secondary Outcomes (4)

  • Change from Baseline Lateral step-down (LSD) test score to 3 weeks

    Baseline and Post testing (week 3)

  • Change from Baseline Isometric knee and hip peak torque values to 3 weeks

    Baseline and Post testing (week 3)

  • Change from Baseline Lower Extremity Functional Scale (LEFS) score to 3 weeks

    Baseline and Post testing (week 3)

  • Change from Baseline Pressure Pain Threshold to 3 weeks

    Baseline and Post testing (week 3)

Study Arms (5)

Glute Dry Needling

EXPERIMENTAL

Receives dry needling to their gluteal muscles in addition to standard physical therapy treatment.

Device: Dry Needling

Quad Dry Needling

EXPERIMENTAL

Receives dry needling to their quadriceps muscles in addition to standard physical therapy treatment.

Device: Dry Needling

Glute Sham Dry Needling

SHAM COMPARATOR

Receives sham dry needling to their gluteal muscles in addition to standard physical therapy treatment.

Device: Sham Dry Needling

Quad Sham Dry Needling

SHAM COMPARATOR

Receives sham dry needling to their quadriceps muscles in addition to standard physical therapy treatment.

Device: Sham Dry Needling

Control

ACTIVE COMPARATOR

Receives only standard physical therapy treatment.

Other: Physical Therapy

Interventions

Physical Therapy and exercise as determined by the examining clinician based on the patients specific impairments and functional limitations. All subjects enrolled in this study will receive an initial physical therapy (PT) evaluation and then 2 additional PT sessions a week a part. Interventions and prescribed home exercises will be specific to the patients' primary individual impairments as determined during the initial PT evaluation. These interventions reflect current evidence, but will not be restrictive to specific exercises; prescribed exercises will be deemed appropriate based on the treating PTs' examination, evaluation, and identification of each patients' primary deficits, impairments, functional limitations, and current literature.

Also known as: Exercise
Control

Dry needling consists of small, monofilament needles that are administered directly into the tissue and manipulated to make the muscle relax for pain relief. This technique is used to treat dysfunctions in skeletal muscle and connective tissue to help diminish pain, reduce impairments of body structure and restore function. Dry needling will be performed in the gluteal or the quadriceps muscle groups depending upon group randomization.

Also known as: Trigger Point Acupunture
Glute Dry NeedlingQuad Dry Needling

The same overall procedures will be used as in the "true" dry needling groups and applied to the same muscle groups (gluteal or quadriceps) depending upon ground randomization. Sham dry needling will be performed using a commercially available sham needling system commonly.This set-up utilizes a blunt tipped needle. When the sham needle is pressed downward, the barrel of the needle retracts into the handle, giving the appearance of insertion of the needle through the skin. This also creates pressure on the subject's skin, increasing the sensation of dry needling. Patients will not be allowed to observe the areas being needled or sham needled.

Glute Sham Dry NeedlingQuad Sham Dry Needling

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years-of-age
  • Referred for physical therapy
  • Presence of anterior knee pain around the patella during ascending/descending stairs, squatting, and/or running for at least 3 months.

You may not qualify if:

  • Unable to provide consent
  • Bilateral patellofemoral pain syndrome
  • Received previous dry needling treatments
  • Pregnancy
  • History of pain less than 3 months
  • Imaging demonstrating the presence of confounding internal abnormality (e.g. chondral defects, ligamentous injury, and/or meniscal pathology),
  • Patellar instability
  • Presence of a neurological condition that would affect movement
  • Contraindications to dry needling techniques (e.g. a history of bleeding disorders, phobia of needles, an active cancer diagnosis, and presence of other systemic illness such as fever or signs of infection)
  • Actively receiving treatment for knee pain outside of the current study protocol while enrolled in the study;
  • received active and supervised PT treatment for knee pain within the last 4 weeks;
  • history of knee surgery less than 6 months ago
  • history of surgical correction of the patellofemoral complex (e.g. MPFL reconstruction, patellar realignment surgery, etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43221, United States

RECRUITING

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Interventions

Dry NeedlingPhysical Therapy ModalitiesExercise

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsRehabilitationMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Matthew S Briggs, DPT, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor-Practice

Study Record Dates

First Submitted

August 29, 2016

First Posted

September 7, 2016

Study Start

August 1, 2016

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2030

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations